CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-28 | MOORE ALISON Chief Technical Officer | Option exercise · Option to Purchase Common Stock (Right to Buy) | −27,816 | 815,856 | ||
| 2019-06-18 | Chang David D President and CEO | Other acquisition | +10,154 | 1,135,498 | ||
| 2019-06-06 | MESSEMER DEBORAH M. Director | Grant or award · Stock Option (Right to Buy) | +26,025 | 26,025 | ||
| 2019-06-06 | Kazam Joshua A Director | Grant or award | +16,377 | 1,407,028 | ||
| 2019-06-06 | Humer Franz B Director | Grant or award | +16,377 | 121,247 | ||
| 2019-06-06 | WITTE OWEN N. Director | Grant or award · Stock Option (Right to Buy) | +26,025 | 26,025 | ||
| 2019-06-03 | MOORE ALISON Chief Technical Officer | Option exercise | +48,828 | $2.27 | $111K | 86,385 |
| 2019-06-03 | MOORE ALISON Chief Technical Officer | Sale | −47,205 | $26.74 | $1.3M | 39,180 |
| 2019-06-03 | MOORE ALISON Chief Technical Officer | Sale | −1,623 | $27.31 | $44K | 37,557 |
| 2019-06-03 | MOORE ALISON Chief Technical Officer | Option exercise · Option to Purchase Common Stock (Right to Buy) | −48,828 | 843,672 | ||
| 2019-05-14 | TPG Group Holdings (SBS) Advisors, Inc. 10% owner | Sale | −1,918,755 | $29.38 | $56.4M | 21,216,306 |
| 2019-05-13 | Belldegrun Arie Director | Other disposition | −598,935 | 4,791,480 | ||
| 2019-05-13 | Belldegrun Arie Director | Other acquisition | +13,413 | 515,076 | ||
| 2019-05-13 | Chang David D President and CEO | Other acquisition | +11,753 | 1,125,344 | ||
| 2019-04-26 | Chang David D President and CEO | Other acquisition | +11,753 | 1,113,591 | ||
| 2019-04-26 | Belldegrun Arie Director | Other disposition | −598,937 | 5,390,415 | ||
| 2019-04-26 | Belldegrun Arie Director | Other acquisition | +13,413 | 501,663 | ||
| 2019-03-13 | MOORE ALISON Chief Technical Officer | Grant or award | +37,050 | 37,050 | ||
| 2019-03-13 | MOORE ALISON Chief Technical Officer | Grant or award · Employee Stock Option (Right to Buy) | +83,500 | 83,500 | ||
| 2019-03-13 | SCHMIDT ERIC THOMAS Chief Financial Officer | Grant or award | +49,400 | 49,400 |
Page 21 of 23 · 451 trades